Nina Delaney Wagner-Johnston MD

Assistant Professor, Internal Medicine, Washington University School of Medicine

1800 Orleans StBaltimore, MD 21287
Phone+1 314-747-1171
Fax+1 314-362-3192

Dr. Wagner-Johnston is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wagner-Johnston's full profile Already have an account?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
University of ChicagoResidency, Internal Medicine, 2003 - 2005
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

DC State Medical License 2022 - 2028
MD State Medical License 2005 - 2027
PA State Medical License 2024 - 2024
MO State Medical License 2008 - 2016
IL State Medical License 2003 - 2006
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Follow My Health, Jardogs, 2013-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification Follow My Health, Jardogs, 2013-2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017

Clinical Trials

Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
COMPLETED
Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue
WITHDRAWN
NA
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
COMPLETED
PHASE2

Publications & Presentations

PubMed

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.
Sanjal H Desai, Susan M Geyer, Levi Pederson, Michael A Spinner, Veronika Bachanova
Blood Cancer Journal. 2026-06-25
Phase I study of oral azacitidine plus salvage chemotherapy in relapsed/refractory diffuse large B-cell lymphoma.
Brian Hess, Nina D Wagner-Johnston, Lindsey Hendrickson, James A Davis, Elizabeth Hill
Annals of Hematology. 2026-06-22
7 citations
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma.
Juan Pablo Alderuccio, Diva Baggio, Sunwoo Han, Paola Ghione, Imran Nizamuddin
Blood. 2026-04-16

Abstracts/Posters

A Phase IB Study of Blinatumomab (blina) in Patients with B Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or M...
Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pat...
Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 Patients
Nina D. Wagner-Johnston, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Treatment Options in MCL: What Are the Best Practices?September 12th, 2024
Pain PointersJune 1st, 2021
Dual Expression of MYC, BCL2 Associated with Poorer Outcomes in DLBCLMay 26th, 2017

Grant Support

Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research FootprintJOHNS HOPKINS UNIVERSITY2023–2028